Accumulating clinical evidence demonstrates that GLP-1 receptor agonists can improve markers of fatty liver disease, though the strength of evidence varies by outcome measure and specific medication
Modifiers applicable to CPT code 01712 Modifier selection determines whether the claim reflects personally performed services, medically directed services, or supervision arrangements
Order Digest Today (tap here) Take 1 capsule with tonights evening meal
Strauss KA, Jinks RN, Puffenberger EG, Venkatesh S, Singh K, Cheng I, et al
Ahead, well unpack why interest is surging while carefully addressing the lack of FDA approval, limited human research, and growing regulatory scrutiny surrounding its use